Jump to content

Megavitamin therapy

From Wikipedia, the free encyclopedia

Megavitamin therapy
ClaimsHealth effects from very high doses of vitamins.
Related scientific disciplinesvitamins,dietary supplements
Year proposed1930s
Notable proponentsFrederick Klenner,Linus Pauling
(Overview of pseudoscientific concepts)

Megavitamin therapyis the use of large doses ofvitamins,often many times greater than therecommended dietary allowance(RDA) in the attempt to prevent or treatdiseases.Megavitamin therapy is typically used inalternative medicineby practitioners who call their approachorthomolecular medicine.[1]Vitamins are useful in preventing and treating illnesses specifically associated with dietary vitamin shortfalls, but the conclusions of medical research are that the broad claims of disease treatment by advocates of megavitamin therapy are unsubstantiated by the available evidence.[2][3]It is generally accepted that doses of any vitamin greatly in excess of nutritional requirements will result either in toxicity (vitamins A and D) or in the excess simply being metabolised; thus evidence in favour of vitamin supplementation supports only doses in the normal range.[4][5][6]Critics have described some aspects of orthomolecular medicine asfood faddismor evenquackery.[7][8][9]Research on nutrient supplementation in general suggests that some nutritional supplements might be beneficial, and that others might be harmful;[10][11][12]several specific nutritional therapies are associated with an increased likelihood of the condition they are meant to prevent.[13]

Multivitamin vs megavitamin

[edit]

Megavitamin therapy must be distinguished from the usual "vitamin supplementation" approach of traditional multivitamin pills. Megavitamin doses are far higher than the levels of vitamins ordinarily available through western diets. A study of 161,000 individuals (post-menopausal women) provided, in the words of the authors, "convincing evidence that multivitamin use has little or no influence on the risk of common cancers, cardiovascular disease, or total mortality in postmenopausal women".[14]

History

[edit]

In the 1930s and 1940s, some scientific and clinical evidence suggested that there might be beneficial uses of vitamins C, E, and niacin in large doses. Beginning in the 1930s inCanada,a megadose vitamin E therapy for cardiovascular and circulatory complaints was developed byEvan Shuteand colleagues, named the "Shute protocol".[15]Tentative experiments in the 1930s byClaus W. Jungeblut[16]with larger doses of vitamin C led to Frederick Klenner's development ofmegadoseintravenous vitamin C treatments for polio and other viruses in the 1940s.[17]William Kaufman published articles in the 1940s that detailed his treatment of arthritis with frequent, high doses of niacinamide.[18]Rudolf Altschul andAbram Hofferapplied large doses of the immediate release form ofniacin(Vitamin B3) to treathypercholesterolemia.[19][20]In a 1956 publication entitledBiochemical Individuality,Roger J. Williamsintroduced concepts for individualized megavitamins and nutrients.[21]Megavitamin therapies were also publicly advocated byLinus Paulingin the late 1960s.[22]

Usage as therapy

[edit]

Although megavitamin therapies still largely remain outside of the structure ofevidence-based medicine,they are increasingly used by patients, with or without the approval of their treating physicians, often after recommendations by practitioners of orthomolecular andnaturopathic medicine.[23]The proposed efficacy of various megavitamin therapies to reduce cancer risk has been contradicted by results of one clinical trial.[24]

Vitamin C

[edit]

The USRecommended Dietary Allowanceforvitamin Cfor adult women is 76 mg/day and for adult men 90 mg/day. AlthoughLinus Paulingwas known for highly respectable research in chemistry and biochemistry, he was also known for promoting the consumption of vitamin C in large doses.[25]Although he claimed and stood firm in his claim that consuming over 1,000 mg is helpful for one’s immune system when fighting a head cold, the results of empirical research do not align with this view. A meta-analysis concluded that supplementary vitamin C significantly lowered serumuric acid,considered a risk factor forgout.[26]One population study reported an inverse correlation between dietary vitamin C and risk of gout.[27]A review of clinical trials in the treatment of colds with small and large doses of Vitamin C has established that there is no evidence that it decreases the incidence ofcommon colds.[28]After 33 years of research, it is still not established whether vitamin C can be used as a treatment for cancer.[29]

Vitamin E

[edit]

The USRecommended Dietary Allowanceforvitamin Efor adult women and men is 15 mg/day. The US Food and Nutrition Board set atolerable upper intake level (UL)at 1,000 mg (1,500 IU) per day derived from animal models that demonstrated bleeding at high doses.[30]In the US, the popularity for vitamin E as a dietary supplement peaked around 2000, with popular doses of 400, 800 and 1000 IU/day. Declines in usage were attributed to publications of meta-analyses that showed either no benefits or negative consequences from vitamin E supplements.[31][32][33][34][35][36]

Niacin

[edit]

The USRecommended Dietary Allowanceforniacinfor adult women is 14 mg/day and for adult men 16 mg/day. Niacin is available as a prescription product, either immediate release (500 mg tablets; prescribed up to 3,000 mg/day) or extended release (500 and 1,000 mg tablets; prescribed up to 2,000 mg/day). In the US, niacin is also available as adietary supplementat 500 to 1,000 mg/tablet. Niacin has sometimes been used in combination with otherlipid-lowering medications.[37]Systematic reviews found no effect of niacin oncardiovascular diseaseor death, in spite of raisinghigh-density lipoprotein(HDL) cholesterol. Reported side effects include an increased risk ofdiabetes.[38][39][40]

See also

[edit]

Related topics

Vitamin topics

References

[edit]
  1. ^Zell M, Grundmann O (2012). "An orthomolecular approach to the prevention and treatment of psychiatric disorders".Adv Mind Body Med.26(2): 14–28.PMID23341413.
  2. ^Aaronson S, et al. (2003)."Cancer medicine".Cancer medicine 6 (Frei, Emil; Kufe, Donald W.; Holland, James F., eds).Hamilton, Ont: BC Decker. pp.76.ISBN978-1-55009-213-4.
  3. ^Nutrition Committee, Canadian Paediatric Society (1990)."Megavitamin and megamineral therapy in childhood. Nutrition Committee, Canadian Paediatric Society".CMAJ.143(10): 1009–1013.PMC1452516.PMID1699646.
  4. ^"What Does Your Body do to Excess Vitamin B or C That You Might Consume?".16 June 2012.
  5. ^"Vitamins & Supplements Center – Nutritional, Herbal, Dietary, and More - WebMD".
  6. ^Novella, S:Medical Myths, Lies, and Half-Truths: What We Think We Know May Be Hurting Us,The Great Courses
  7. ^Jarvis WT (1983). "Food faddism, cultism, and quackery".Annu. Rev. Nutr.3:35–52.doi:10.1146/annurev.nu.03.070183.000343.PMID6315036.
  8. ^Jukes TH (1990)."Nutrition Science from Vitamins to Molecular Biology".Annual Review of Nutrition.10(1): 1–20.doi:10.1146/annurev.nu.10.070190.000245.PMID2200458.A short summary is inthe journal's preface.
  9. ^Braganza, S.F., Ozuah, P.O. (2005). "Fad Therapies".Pediatrics in Review.26(10): 371–376.doi:10.1542/pir.26-10-371.PMID16199591.
  10. ^"NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention".NIH Consens State Sci Statements.23(2): 1–30. 2006.PMID17332802.Archived fromthe originalon 2009-02-21.Retrieved2009-02-18.
  11. ^Huang HY, Caballero B, Chang S, et al. (2006)."The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference".Ann. Intern. Med.145(5): 372–385.doi:10.1001/archinte.145.2.372.PMID16880453.
  12. ^Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2012)."Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases".Cochrane Database Syst Rev.2012(3): CD007176.doi:10.1002/14651858.CD007176.pub2.hdl:10138/136201.PMC8407395.PMID22419320.
  13. ^Satia JA, Littman A, Slatore CG, Galanko JA, White E (2009)."Long-term Use of {beta}-Carotene, Retinol, Lycopene, and Lutein Supplements and Lung Cancer Risk: Results From the VITamins And Lifestyle (VITAL) Study".American Journal of Epidemiology.169(7): 815–828.doi:10.1093/aje/kwn409.PMC2842198.PMID19208726.
  14. ^Neuhouser ML, Wassertheil-Smoller S, Thomson C, et al. (2009)."Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts".Arch. Intern. Med.169(3): 294–304.doi:10.1001/archinternmed.2008.540.PMC3868488.PMID19204221.
  15. ^Vogelsang A, Shute E, Shute W (1948). "Some medical uses of vitamin E".Med World (New York).161(2): 83–89.PMID18911314.
  16. ^Jungeblut CW (1937)."Vitamin C Therapy and Prophylaxis in Experimental Poliomyelitis".The Journal of Experimental Medicine.65(1): 127–146.doi:10.1084/jem.65.1.127.PMC2133474.PMID19870585.
  17. ^Klenner, Fred R. (1949). "The treatment of poliomyelitis and other virus diseases with vitamin C".Southern Medicine & Surgery.111(7): 209–214.PMID18147027.
  18. ^KAUFMAN W (July 1953). "Niacinamide therapy for joint mobility; therapeutic reversal of a common clinical manifestation of the normal aging process".Conn State Med J.17(7): 584–9.PMID13060032.
  19. ^Altschul R, Hoffer A, Stephen JD (1955). "Influence of nicotinic acid on serum cholesterol in man".Arch. Biochem. Biophys.54(2): 558–559.doi:10.1016/0003-9861(55)90070-9.PMID14350806.
  20. ^Altschul R, Hoffer A (1960)."The Effect of Nicotinic Acid on Hypercholesterolæmia".Can Med Assoc J.82(15): 783–785.PMC1938010.PMID13792994.
  21. ^Williams, Roger Lawrence (1998).Biochemical Individuality.New York: McGraw-Hill.ISBN978-0-87983-893-5.
  22. ^Stone, Irwin (1982).The healing factor: "vitamin C" against disease.New York: Perigee Books.ISBN978-0-399-50764-9.
  23. ^Richardson MA, Sanders T,Palmer JL,Greisinger A, Singletary SE (2000). "Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology".J. Clin. Oncol.18(13): 2505–2514.doi:10.1200/JCO.2000.18.13.2505.PMID10893280.
  24. ^Lin J, Cook NR, Albert C, et al. (2009)."Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial".J. Natl. Cancer Inst.101(1): 14–23.doi:10.1093/jnci/djn438.PMC2615459.PMID19116389.
  25. ^Cameron E, Pauling L (October 1976)."Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer".Proceedings of the National Academy of Sciences of the United States of America.73(10): 3685–9.Bibcode:1976PNAS...73.3685C.doi:10.1073/pnas.73.10.3685.PMC431183.PMID1068480.
  26. ^Juraschek SP, Miller ER, Gelber AC (September 2011)."Effect of oral vitamin C supplementation on serum uric acid: a meta-analysis of randomized controlled trials".Arthritis Care & Research.63(9): 1295–306.doi:10.1002/acr.20519.PMC3169708.PMID21671418.
  27. ^Choi HK, Xiang Gao, Gary Curhan (2009)."Vitamin C Intake and the Risk of Gout in Men – A Prospective Study".Archives of Internal Medicine.169(5): 502–507.doi:10.1001/archinternmed.2008.606.PMC2767211.PMID19273781.
  28. ^Hemilä H, Chalker E (2013-01-31)."Vitamin C for preventing and treating the common cold".The Cochrane Database of Systematic Reviews.2013(1): CD000980.doi:10.1002/14651858.CD000980.pub4.ISSN1469-493X.PMC1160577.PMID23440782.
  29. ^Cabanillas F (2010). "Vitamin C and cancer: what can we conclude--1,609 patients and 33 years later?".Puerto Rico Health Sciences Journal.29(3): 215–217.PMID20799507.
  30. ^Institute of Medicine(2000)."Vitamin E".Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids.Washington, DC: The National Academies Press. pp. 186–283.doi:10.17226/9810.ISBN978-0-309-06935-9.PMID25077263.
  31. ^Kim HJ, Giovannucci E, Rosner B, Willett WC, Cho E (2014)."Longitudinal and secular trends in dietary supplement use: Nurses' Health Study and Health Professionals Follow-Up Study, 1986-2006".J Acad Nutr Diet.114(3): 436–443.doi:10.1016/j.jand.2013.07.039.PMC3944223.PMID24119503.
  32. ^Eidelman RS, Hollar D, Hebert PR, Lamas GA, Hennekens CH (2004). "Randomized trials of vitamin E in the treatment and prevention of cardiovascular disease".Archives of Internal Medicine.164(14): 1552–56.doi:10.1001/archinte.164.14.1552.PMID15277288.
  33. ^Abner EL, Schmitt FA, Mendiondo MS, Marcum JL, Kryscio RJ (July 2011)."Vitamin E and all-cause mortality: a meta-analysis".Current Aging Science.4(2): 158–70.doi:10.2174/1874609811104020158.PMC4030744.PMID21235492.
  34. ^Curtis AJ, Bullen M, Piccenna L, McNeil JJ (December 2014). "Vitamin E supplementation and mortality in healthy people: a meta-analysis of randomised controlled trials".Cardiovasc Drugs Ther.28(6): 563–73.doi:10.1007/s10557-014-6560-7.PMID25398301.S2CID23820017.
  35. ^Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (January 2005). "Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality".Annals of Internal Medicine.142(1): 37–46.doi:10.7326/0003-4819-142-1-200501040-00110.PMID15537682.S2CID35030072.
  36. ^Bjelakovic G, Nikolova D, Gluud C (2013)."Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?".PLOS ONE.8(9): e74558.Bibcode:2013PLoSO...874558B.doi:10.1371/journal.pone.0074558.PMC3765487.PMID24040282.
  37. ^Niacin tablet labelUpdated March 14, 2013. Page accessed Feb 11, 2016
  38. ^Keene D, Price C, Shun-Shin MJ, Francis DP (July 2014)."Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients".BMJ.349:g4379.doi:10.1136/bmj.g4379.PMC4103514.PMID25038074.
  39. ^Schandelmaier S, Briel M, Saccilotto R, Olu KK, Arpagaus A, Hemkens LG, Nordmann AJ (June 2017)."Niacin for primary and secondary prevention of cardiovascular events".The Cochrane Database of Systematic Reviews.2017(6): CD009744.doi:10.1002/14651858.CD009744.pub2.PMC6481694.PMID28616955.
  40. ^Garg A, Sharma A, Krishnamoorthy P, Garg J, Virmani D, Sharma T, Stefanini G, Kostis JB, Mukherjee D, Sikorskaya E (2017)."Role of Niacin in Current Clinical Practice: A Systematic Review".The American Journal of Medicine.130(2): 173–187.doi:10.1016/j.amjmed.2016.07.038.PMID27793642.
[edit]